Vertex Pharma scientist talks about the long road to developing non
WASHINGTON (AP) — For decades, patients seeking medication for pain have had two choices: over-the-counter drugs like aspirin or powerful prescription opioids like oxycodone.
Opioid prescriptions have plummeted over the last decade as doctors have become more attuned to the risks of addiction and misuse during the country’s ongoing drug epidemic.
Vertex Pharmaceuticals recently reported positive results for a non-opioid painkiller, one of several medications the Boston-based drugmaker has been developing for various forms of pain. Patients taking the drug after surgery experienced more pain relief than those getting a placebo, although the drug didn’t meet a secondary goal of outperforming treatment with an opioid.
The Associated Press spoke with Vertex’s chief scientist Dr. David Altshuler about the company’s research and development plans. The interview has been edited for length and clarity.
Related articles
Kristin Cavallari, 37, ignores critics of her age
Kristin Cavallari is enjoying a romantic rendezvous with her much younger cowboy lover Mark Estes in2024-05-22From the fabulous 'Elvis Dress' to the velvet gown she wore dancing with Travolta
WHEN the first dress that Jacques Azagury designed for Princess Diana broke records late last year a2024-05-22Queen Letizia and King Felipe of Spain visit Queen Sofia, 85, in hospital
Queen Letizia of Spain visited Queen Sofia in hospital on Thursday evening - as she now enters her t2024-05-22What would open warfare between Israel and Iran look like? How tit
The outbreak of war between Israel and Hamas following the October 7 attacks rocked the already prec2024-05-22French sports minister calls for sanctions after Monaco player tapes over anti
PARIS (AP) — France’s sports minister has called for soccer club Monaco to be sanctioned after one o2024-05-22Will polo's 'David Beckham' and his ultra
As Prince Harry and Meghan Markle prepare to launch two new Netflix series as part of their $100 mil2024-05-22
atest comment